Literature DB >> 8997292

Influence of acute-phase proteins on erythrocyte aggregation.

X Weng1, G Cloutier, R Beaulieu, G O Roederer.   

Abstract

With the exception of fibrinogen, immunoglobulins, and albumin, little information is available on the effect of acute-phase proteins on erythrocyte aggregation. The objective of this study was to investigate the effects of haptoglobin (Hp), C-reactive protein (CRP), ceruloplasmin (Cp), alpha 1-acid glycoprotein (alpha 1-AGP), and alpha 1-antitrypsin (alpha 1-AT) on the aggregation kinetics and shear resistance of erythrocyte aggregates. The plasma concentration of these proteins was measured in 20 healthy individuals and kept unchanged while the concentration of the protein tested was increased. Adding Hp to concentrations between 2.78 and 4.99 g/l resulted in a significant progressive increase in aggregation kinetics compared with controls. An elevation of the shear resistance of the aggregates was found for CRP at a concentration of 0.438 g/l. By an increase in the concentration of Cp from 4.40 to 9.39 g/l, the aggregation kinetics and the adhesive forces between erythrocytes were significantly increased: No effect on erythrocyte aggregation was observed for alpha 1-AGP, alpha 1-AT, and Cp at concentrations of 2.85, 3.97, and 2.43 g/l, respectively. The molecular mass of the acute-phase proteins, their configuration, and the presence of specific receptors on the erythrocyte membrane are postulated as possible factors influencing erythrocyte aggregation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8997292     DOI: 10.1152/ajpheart.1996.271.6.H2346

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  17 in total

1.  Simulation of ultrasound backscattering by red cell aggregates: effect of shear rate and anisotropy.

Authors:  Isabelle Fontaine; David Savéry; Guy Cloutier
Journal:  Biophys J       Date:  2002-04       Impact factor: 4.033

2.  Involvement of fibrinogen specific binding in erythrocyte aggregation.

Authors:  David Lominadze; William L Dean
Journal:  FEBS Lett       Date:  2002-04-24       Impact factor: 4.124

3.  The hydrodynamic radii of macromolecules and their effect on red blood cell aggregation.

Authors:  J K Armstrong; R B Wenby; H J Meiselman; T C Fisher
Journal:  Biophys J       Date:  2004-09-10       Impact factor: 4.033

4.  Blood rheological properties in patients with atopic dermatitis (AD).

Authors:  A Kasperska-Zajac; Z Brzoza; E Koczy-Baron; J Jagodzinska; L Slowinska; B Rogala
Journal:  Inflammation       Date:  2009-08       Impact factor: 4.092

5.  Diagnosis of sepsis from a drop of blood by measurement of spontaneous neutrophil motility in a microfluidic assay.

Authors:  Felix Ellett; Julianne Jorgensen; Anika L Marand; Yuk Ming Liu; Myriam M Martinez; Vicki Sein; Kathryn L Butler; Jarone Lee; Daniel Irimia
Journal:  Nat Biomed Eng       Date:  2018-03-19       Impact factor: 25.671

6.  Inflammation-related erythrocyte aggregation in patients with inflammatory bowel disease.

Authors:  Liaz Zilberman; Ori Rogowski; Meirav Rozenblat; Itzhak Shapira; Jacob Serov; Pinhas Halpern; Iris Dotan; Nadir Arber; Shlomo Berliner
Journal:  Dig Dis Sci       Date:  2005-04       Impact factor: 3.199

Review 7.  The clinical significance of whole blood viscosity in (cardio)vascular medicine.

Authors:  G A M Pop; D J Duncker; M Gardien; P Vranckx; S Versluis; D Hasan; C J Slager
Journal:  Neth Heart J       Date:  2002-12       Impact factor: 2.380

8.  Increased ability of erythrocytes to aggregate in spontaneously hypertensive rats.

Authors:  David Lominadze; Dale A Schuschke; Irving G Joshua; William L Dean
Journal:  Clin Exp Hypertens       Date:  2002-07       Impact factor: 1.749

9.  Therapeutic potentials of pentoxifylline for treatment of cardiovascular diseases.

Authors:  Ming Zhang; Yan-Jun Xu; Shushma A Mengi; Amarjit S Arneja; Naranjan S Dhalla
Journal:  Exp Clin Cardiol       Date:  2004

10.  Sex differences in the expression of haemorheological determinants in individuals with atherothrombotic risk factors and in apparently healthy people.

Authors:  D Zeltser; O Rogowski; S Berliner; T Mardi; D Justo; J Serov; M Rozenblat; D Avitzour; I Shapira
Journal:  Heart       Date:  2004-03       Impact factor: 5.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.